| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Van Der Ploeg Leonardus H.T. serves as a Chief Scientific Officer at RYTM. Across recent SEC filings that breaks down to 0 buys and 11 sells. Those positions are worth an estimated $1.1M at current prices.
The biggest single holding is RYTM (~$1.1M) as Chief Scientific Officer. The recent filings there lean toward selling, a net 95,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 31, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $25.21 | $252,050.00 | -19.1% | |
| May 29, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 15,000 | $25.42 | $381,350.00 | -26.2% | |
| Jan 16, 2019 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 200 | $30.00 | $6,000.00 | -0.5% | |
| Nov 2, 2018 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 38,000 | $30.09 | $1,143,420.00 | -47.2% | |
| Sep 25, 2018 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 31,800 | $29.80 | $947,539.94 | -37.8% |